Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-20-000015

President and CEO gave up 2,462 shares (to pay taxes)

  • President and CEO acquired 33,366 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kramer Robert · President and CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-25 Grant or award : show line 1 in the form +16,683 128,077 D
2020-02-25 Grant or award : show line 2 in the form +16,683 144,760 D
2020-02-26 Shares withheld for taxes : show line 3 in the form −558 $59.91 $33,430 144,202 D
2020-02-27 Shares withheld for taxes : show line 4 in the form −778 $58.42 $45,451 143,424 D
2020-02-26 Shares withheld for taxes : show line 5 in the form −1,126 $59.91 $67,459 142,298 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-02-25 Grant or award : show line 6 in the form Employee Stock Options (Right to Buy) +66,731 $61.44 $4,099,953 113,928 D
Loading xslF345X03/wf-form4_158285623669698.xml…